Jushi Holdings (JUSHF) Income towards Parent Company (2021 - 2026)
Jushi Holdings (JUSHF) reported Income towards Parent Company of -$19.8 million for Q1 2026, down 16.64% year-over-year from -$23.8 million in Q1 2025, and down 27.58% quarter-over-quarter from -$15.6 million in Q4 2025.
Jushi Holdings (JUSHF) Income towards Parent Company (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Income towards Parent Company data on file, last reported at -$19.8 million in Q1 2026.
- Income towards Parent Company for Q1 2026 came in at -$19.8 million, down 16.64% year-over-year; the trailing twelve-month figure through Mar 2026 was -$71.4 million (down 50.56% YoY), and the FY2025 annual result was -$68.6 million, down 40.62% from the prior year.
- Income towards Parent Company slipped to -$19.8 million in Q1 2026 per JUSHF's latest filing, from -$15.6 million in the prior quarter.
- Over five years, Income towards Parent Company peaked at $12.1 million in Q2 2022 and troughed at -$139.9 million in Q4 2022.
- A 5-year average of -$23.8 million and a median of -$17.0 million in 2025 frame the typical range for Income towards Parent Company.
- On a YoY basis, Income towards Parent Company climbed as much as 357.74% in 2022 and fell as far as 2353.05% in 2022.
- A 5-year view of Income towards Parent Company shows it stood at -$139.9 million in 2022, then surged by 87.13% to -$18.0 million in 2023, then surged by 30.75% to -$12.5 million in 2024, then dropped by 24.77% to -$15.6 million in 2025, then slipped by 27.58% to -$19.8 million in 2026.
- Business Quant data shows JUSHF's Income towards Parent Company at -$19.8 million in Q1 2026, -$15.6 million in Q4 2025, and -$23.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.85 Mn |
| Dec 31, 2025 | -15.56 Mn |
| Sep 30, 2025 | -23.69 Mn |
| Jun 30, 2025 | -12.33 Mn |
| Mar 31, 2025 | -17.02 Mn |
| Dec 31, 2024 | -12.47 Mn |
| Sep 30, 2024 | -16.02 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | -18.36 Mn |
| Dec 31, 2023 | -18.00 Mn |
| Sep 30, 2023 | -20.62 Mn |
| Jun 30, 2023 | -14.04 Mn |
| Mar 31, 2023 | -12.44 Mn |
| Dec 31, 2022 | -139.94 Mn |
| Sep 30, 2022 | -54.70 Mn |
| Jun 30, 2022 | 12.07 Mn |
| Mar 31, 2022 | -19.76 Mn |
| Dec 31, 2021 | 6.21 Mn |
| Sep 30, 2021 | 39.68 Mn |
| Jun 30, 2021 | 2.64 Mn |